Emily K Stoneman
Clinical Associate Professor of Internal Medicine
Associate Hospital Epidemiologist and Infection Control Director
Occupational Health Services
Internal Medicine
Division of Infectious Diseases
1500 East Medical Center Drive, F4007 University Hospital South
Ann Arbor, Michigan 48109
[email protected]

Available to mentor

Emily K Stoneman
Clinical Associate Professor
  • About
  • Qualifications
  • Recent Publications
  • About

    Dr. Stoneman is board certified in Infectious Diseases. She is an Associate Professor in the Department of Internal Medicine, Division of Infectious Diseases. Her clinical responsibilities include seeing patients with infectious disease in the inpatient and outpatient settings. Dr. Stoneman is also an Associate Hospital Epidemiologist in the Department of Infection Prevention and Epidemiology, where she works to reduce healthcare-associated infections, and Medical Director of Occupational Health Services. Dr. Stoneman completed her clinical training at the University of Michigan and worked at New York-Presbyterian – Weill Cornell Medical College prior to returning to the University of Michigan in 2014 to assume her current roles. Her clinical interests include general infectious diseases and management of exposures to infectious diseases. Her research interests include healthcare-associated infections and COVID-19 immunity.

    Qualifications
    • Fellow
      University of Michigan, Ann Arbor, 2009
    • Resident Physician
      University of Michigan, Ann Arbor, 2006
    • Certificate in the Foundations of Public Health
      University of Michigan School of Public Health, Ann Arbor, 2009
    • MD
      Vanderbilt University, 215 Light Hall, 2003
    • BS
      University of Michigan, Ann Arbor, 1999
    Recent Publications See All Publications
    • Presentation
      Michigan Sustainable Business Forum/Michigan Clinicians for Climate Action Webinar on Infectious Diseases and Climate Change
      2024 Dec 10;
    • Presentation
      Public Health Medley: A Diverse Mix of Topics and Trends
      2024 Oct 18;
    • Preprint
      SARS-CoV-2 Omicron BA.2.87.1 Exhibits Higher Susceptibility to Serum Neutralization Than EG.5.1 and JN.1
      Wang Q, Guo Y, Schwanz L, Mellis I, Sun Y, Qu Y, Urtecho G, Valdez R, Stoneman E, Gordon A, Wang H, Liu L, Ho D. 2024 bioRxiv, DOI:10.1101/2024.03.10.584306
    • Journal Article
      Management of Candida auris.
      Wasylyshyn A, Stoneman EK. JAMA, 2024 Feb 20; 331 (7): 611 - 612. DOI:10.1001/jama.2023.24921
      PMID: 38252429
    • Journal Article
      SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1.
      Wang Q, Guo Y, Schwanz LT, Mellis IA, Sun Y, Qu Y, Urtecho G, Valdez R, Stoneman E, Gordon A, Wang HH, Ho DD, Liu L. Emerg Microbes Infect, 2024 Dec; 13 (1): 2359004 DOI:10.1080/22221751.2024.2359004
      PMID: 38779718
    • Journal Article
      SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
      Wang Q, Bowen A, Ho J, Zhang RM, Valdez R, Stoneman E, Gordon A, Liu L, Ho DD. Lancet, 2023 Nov 18; 402 (10415): 1827 - 1828. DOI:10.1016/S0140-6736(23)02278-X
      PMID: 37922920
    • Preprint
      SARS-CoV-2 Neutralizing Antibodies Following a Second BA.5 Bivalent Booster
      Wang Q, Bowen A, Ho J, Zhang R, Valdez R, Stoneman E, Gordon A, Liu L, Ho D. 2023 bioRxiv, DOI:10.1101/2023.08.13.553148
    • Presentation
      Bloodborne Pathogen Exposures - Beyond the Big 3
      Stoneman E. 2023 May 19;